Literature DB >> 11548178

The ability of plain radiography to predict intracranial aneurysm occlusion instability during follow-up of endosaccular treatment with Gugliemi detachable coils.

S E Connor1, R J West, D A Yates.   

Abstract

Incomplete occlusion of an intracranial aneurysm at follow-up after treatment with Gugliemi detachable coils (GDC) increases the risk of rebleeding and serial angiographic monitoring is therefore currently indicated. We aimed to determine if a change in the plain radiographic appearances of the GDC ball could accurately predict the presence of unstable angiographic occlusion. Paired GDC radiographs (in two planes) and cerebral angiograms, performed immediately after treatment and at follow-up or at two consecutive follow-up examinations, were retrospectively compared. Radiographs were assessed for the radiographic change (loosening, compaction or reorientation) in the coil-ball and angiograms for unstable aneurysm occlusion (neck recurrence or deteriorating occlusion). We compared 49 paired films from 38 patients. Radiographic change in the coil ball had a negative predictive value of 96%, positive predictive value of 57% and accuracy of 76% for the presence of angiographic aneurysm instability. It may be possible to increase the interval between follow-up angiographic examinations after GDC treatment safely if there is no change in the radiographic appearances in two planes.

Entities:  

Mesh:

Year:  2001        PMID: 11548178     DOI: 10.1007/s002340000533

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  8 in total

1.  Optical coherence tomography: a new method to assess aneurysm healing.

Authors:  William E Thorell; Michael M Chow; Richard A Prayson; Mark A Shure; Sung W Jeon; David Huang; Emil Zeynalov; Henry H Woo; Peter A Rasmussen; Andrew M Rollins; Thomas J Masaryk
Journal:  J Neurosurg       Date:  2005-02       Impact factor: 5.115

2.  Treatment of cerebral aneurysms with hydrogel-coated platinum coils (HydroCoil): early single-center experience.

Authors:  A Berenstein; J K Song; Y Niimi; K Namba; N S Heran; J L Brisman; M C Nahoum; M Madrid; D J Langer; M J Kupersmith
Journal:  AJNR Am J Neuroradiol       Date:  2006-10       Impact factor: 3.825

3.  Surveillance of intracranial aneurysms treated with detachable coils: a comparison of MRA techniques.

Authors:  Richard I Farb; Shudeshna Nag; James N Scott; Robert A Willinsky; Thomas R Marotta; Walter J Montanera; George Tomlinson; Karel G Terbrugge
Journal:  Neuroradiology       Date:  2005-06-10       Impact factor: 2.804

4.  Efficacy of skull plain films in follow-up evaluation of cerebral aneurysms treated with detachable coils: quantitative assessment of coil mass.

Authors:  S J Ahn; B M Kim; W S Jung; S H Suh
Journal:  AJNR Am J Neuroradiol       Date:  2014-10-16       Impact factor: 3.825

5.  Flat panel detector angiographic CT for stent-assisted coil embolization of broad-based cerebral aneurysms.

Authors:  G Richter; T Engelhorn; T Struffert; M Doelken; O Ganslandt; J Hornegger; W A Kalender; A Doerfler
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-24       Impact factor: 3.825

6.  MR angiographic evaluation is limited in intracranial aneurysms embolized with Nexus coils.

Authors:  Hyun-Seung Kang; Won-Jin Moon; Hong Gee Roh; Moon Hee Han; Woo Jin Choe; Joon Cho; Chang-Taek Moon; Young Cho Koh
Journal:  Neuroradiology       Date:  2007-10-25       Impact factor: 2.804

7.  Follow-up of intracranial aneurysms treated with detachable coils: comparison of plain radiographs, 3D time-of-flight MRA and digital subtraction angiography.

Authors:  J P Cottier; A Bleuzen-Couthon; S Gallas; C B Vinikoff-Sonier; P Bertrand; F Domengie; L Barantin; D Herbreteau
Journal:  Neuroradiology       Date:  2003-10-08       Impact factor: 2.804

8.  Usefulness of Craniograms in Discriminating Coiled Intracranial Aneurysms Requiring Retreatment.

Authors:  Ryuta Yasuda; Tetsu Satow; Naoki Hashimura; Masaki Nishimura; Jun C Takahashi; Hiroharu Kataoka
Journal:  Neurol Med Chir (Tokyo)       Date:  2021-12-08       Impact factor: 1.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.